结核病
结核病(TB)目前是全球感染性死亡的首位原因,影像学在其管理中作用重要。18F-FDG-PET/CT对全身多数部位结核早期检测非常敏感,但缺乏特异性是主要局限;其可全身成像、提供治疗前代谢图、评估疾病负荷、选择活检部位、分期并发现未知病灶,近期研究显示其可能识别潜伏感染中的亚临床病变并预测从潜伏向活动性感染的进展,其他PET示踪剂亦有初步研究。
要点
- 18F-FDG-PET/CT对全身多数部位结核早期检测非常敏感,但缺乏特异性是主要局限。
- 18F-FDG-PET/CT可全身成像、提供治疗前代谢图、评估疾病负荷、选择活检部位、分期并发现未知病灶。
- 18F-FDG-PET/CT近期显示可能识别潜伏结核感染中伴亚临床病变的患者,肺部炎症可能预测从潜伏向活动性感染的进展。
核心结论
- 18F-FDG-PET/CT对全身多数部位结核早期检测非常敏感,但缺乏特异性是主要限制。
- 18F-FDG-PET/CT可提供治疗前代谢图、准确评估疾病负荷、选择最适活检部位、分期并发现未知部位病变。
- 18F-FDG-PET/CT近期显示可能识别潜伏结核感染中伴亚临床病变的患者,肺部炎症可能是有用的从潜伏向活动性感染进展的预测指标。
- 多项研究已识别可能提高18F-FDG-PET/CT在部分肺外结核部位特异性的影像特征,其他PET示踪剂在结核中的应用亦有初步有希望的结果。
研究设计与样本
- 本文为关于PET/CT在结核病成像中应用的综述,基于文献总结18F-FDG-PET/CT及其他PET示踪剂在结核病中的应用。
- 关于18F-FDG-PET/CT评估结核治疗反应的大量文献另有专篇综述讨论。
主要发现
- 18F-FDG-PET/CT对全身多数部位结核早期检测非常敏感,但缺乏特异性是主要局限。
- 18F-FDG-PET/CT可全身成像并提供治疗前感染代谢图,使临床医生能准确评估疾病负荷。
- 18F-FDG-PET/CT可选择最适活检部位、对感染分期并检测先前未知部位的病变。
- 18F-FDG-PET/CT近期显示能识别潜伏结核感染中伴亚临床病变的一部分患者。
- 18F-FDG-PET/CT检测的肺部炎症显示有希望成为从潜伏向活动性感染进展的有用预测指标,多项研究已识别可能提高部分肺外结核部位特异性的影像特征。
局限性
- 18F-FDG-PET/CT缺乏特异性是主要局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tuberculosis (TB) is currently the world's leading cause of infectious mortality. Imaging plays an important role in the management of this disease. The complex immune response of the human body to Mycobacterium tuberculosis results in a wide array of clinical manifestations, making clinical and radiological diagnosis challenging. 18F-FDG-PET/CT is very sensitive in the early detection of TB in most parts of the body; however, the lack of specificity is a major limitation. 18F-FDG-PET/CT images the whole body and provides a pre-therapeutic metabolic map of the infection, enabling clinicians to accurately assess the burden of disease. It enables the most appropriate site of biopsy to be selected, stages the infection, and detects disease in previously unknown sites. 18F-FDG-PET/CT has recently been shown to be able to identify a subset of patients with latent TB infection who have subclinical disease. Lung inflammation as detected by 18F-FDG-PET/CT has shown promising signs that it may be a useful predictor of progression from latent to active infection. A number of studies have identified imaging features that might improve the specificity of 18F-FDG-PET/CT at some sites of extrapulmonary TB. Other PET tracers have also been investigated for their use in TB, with some promising results. The potential role and future perspectives of PET/CT in imaging TB is considered. Literature abounds on the very important role of 18F-FDG-PET/CT in assessing therapy response in TB. The use of 18F-FDG for monitoring response to treatment is addressed in a separate review.
引用
- Ankrah AO, Glaudemans AWJM, Maes A, et al. Tuberculosis. Semin Nucl Med. 2017. PMID: 29452616. doi:10.1053/j.semnuclmed.2017.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。